메뉴 건너뛰기




Volumn 24, Issue 1, 2010, Pages 40-47

Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation

Author keywords

Acute rejection; African Americans; Antilymphocyte antibodies; Graft outcomes; Induction therapy; Interleukin 2; Kidney transplantation; Receptor antibodies

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 74949129484     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00974.x     Document Type: Article
Times cited : (9)

References (20)
  • 1
    • 74949142053 scopus 로고    scopus 로고
    • Available at: , accessed July 7, 2007
    • Current U.S. Waiting List: Organ by Ethnicity 2007, http://www.optn.org/latestData/rptData.asp, Available at: , accessed July 7, 2007
    • (2007) Current U.S. Waiting List: Organ by Ethnicity
  • 3
    • 0034707131 scopus 로고    scopus 로고
    • Renal transplantation in black Americans
    • Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med 2000, 343:1545.
    • (2000) N Engl J Med , vol.343 , pp. 1545
    • Young, C.J.1    Gaston, R.S.2
  • 5
    • 0032494410 scopus 로고    scopus 로고
    • Barriers to cadaveric renal transplantation among blacks, women, and the poor
    • Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998, 280:1148.
    • (1998) JAMA , vol.280 , pp. 1148
    • Alexander, G.C.1    Sehgal, A.R.2
  • 6
    • 21644442638 scopus 로고    scopus 로고
    • Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs
    • Chakkera HA, O'Hare AM, Johansen KL. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol 2005, 16:269.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 269
    • Chakkera, H.A.1    O'Hare, A.M.2    Johansen, K.L.3
  • 7
    • 0034707128 scopus 로고    scopus 로고
    • Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse?
    • Epstein AM, Ayanian JZ, Keogh KH. Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse? N Engl J Med 2000, 343:1537.
    • (2000) N Engl J Med , vol.343 , pp. 1537
    • Epstein, A.M.1    Ayanian, J.Z.2    Keogh, K.H.3
  • 8
    • 0033604594 scopus 로고    scopus 로고
    • The effect of patients' preferences on racial differences in acess to renal transplantation
    • Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients' preferences on racial differences in acess to renal transplantation. N Engl J Med 1999, 341:1661.
    • (1999) N Engl J Med , vol.341 , pp. 1661
    • Ayanian, J.Z.1    Cleary, P.D.2    Weissman, J.S.3    Epstein, A.M.4
  • 9
    • 33846997851 scopus 로고    scopus 로고
    • The rocky road of limited immunosuppression for renal transplantation in African Americans
    • Braun WE. The rocky road of limited immunosuppression for renal transplantation in African Americans. Transplantation 2007, 83:267.
    • (2007) Transplantation , vol.83 , pp. 267
    • Braun, W.E.1
  • 10
    • 0032570530 scopus 로고    scopus 로고
    • Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine
    • Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. Transplantation 1998, 65:515.
    • (1998) Transplantation , vol.65 , pp. 515
    • Neylan, J.F.1
  • 11
    • 0034905252 scopus 로고    scopus 로고
    • Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplatation: results at 2 years
    • Ahsan N, Johnson C, Gonwa T. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplatation: results at 2 years. Transplantation 2001, 72:245.
    • (2001) Transplantation , vol.72 , pp. 245
    • Ahsan, N.1    Johnson, C.2    Gonwa, T.3
  • 12
    • 33846079180 scopus 로고    scopus 로고
    • Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation
    • Al Najjar A, Etienne I, Le Pogamp P. Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation. Transplant Proc 2006, 38:2298.
    • (2006) Transplant Proc , vol.38 , pp. 2298
    • Al Najjar, A.1    Etienne, I.2    Le Pogamp, P.3
  • 14
    • 15944361913 scopus 로고    scopus 로고
    • Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens
    • Nashan B. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens. Biodrugs 2005, 19:39.
    • (2005) Biodrugs , vol.19 , pp. 39
    • Nashan, B.1
  • 15
    • 0032524442 scopus 로고    scopus 로고
    • The effect of antilymphocyte induction therapy of renal allograft survival. A meta-analysis of individual patient-level data
    • Szczech LA, Berlin JA, Feldman HI. The effect of antilymphocyte induction therapy of renal allograft survival. A meta-analysis of individual patient-level data. Ann Intern Med 1998, 128:817.
    • (1998) Ann Intern Med , vol.128 , pp. 817
    • Szczech, L.A.1    Berlin, J.A.2    Feldman, H.I.3
  • 16
    • 16244423303 scopus 로고    scopus 로고
    • Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients
    • Haririan A, Morawski K, Sillix DH. Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients. Transplantation 2005, 79:716.
    • (2005) Transplantation , vol.79 , pp. 716
    • Haririan, A.1    Morawski, K.2    Sillix, D.H.3
  • 18
    • 4644258361 scopus 로고    scopus 로고
    • The selective use of basiliximab versus Thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function
    • Knight RJ, Kerman RH, Schoenberg L. The selective use of basiliximab versus Thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function. Transplantation 2004, 78:904.
    • (2004) Transplantation , vol.78 , pp. 904
    • Knight, R.J.1    Kerman, R.H.2    Schoenberg, L.3    et al4
  • 19
    • 0035667590 scopus 로고    scopus 로고
    • Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection
    • Sollinger H, Kaplan B, Pescovitz S. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation 2001, 72:1915.
    • (2001) Transplantation , vol.72 , pp. 1915
    • Sollinger, H.1    Kaplan, B.2    Pescovitz, S.3
  • 20
    • 19244366185 scopus 로고    scopus 로고
    • Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy
    • Lebranchu Y, Bridoux F, Büchler M. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant 2002, 2:48.
    • (2002) Am J Transplant , vol.2 , pp. 48
    • Lebranchu, Y.1    Bridoux, F.2    Büchler, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.